Details concerning the Ambroxol Hydrochloride combination medication encompass its pricing as well as its availability in various forms, including tablets, capsules, syrups, creams, gels, ointments, ...

Details concerning the Ambroxol Hydrochloride (SR) combination medication encompass its pricing as well as its availability in various forms, including tablets, capsules, syrups, creams, gels, ...

Researchers at Lawson Research Institute are studying Ambroxol - a common cough medicine in Europe - as a potential treatment for dementia linked to Parkinson’s disease LONDON, Ont. – Dementia poses a ...

Global consumer healthcare company iNova Pharmaceuticals continues its growth trajectory in Asia with the Philippine launch ...

Today’s cough syrup could turn into tomorrow’s treatment for Parkinson’s disease. Recent research in the U.K. is the latest to suggest that a common ingredient in cough syrup, ambroxol, might be able ...

Please provide your email address to receive an email when new articles are posted on . Oral ambroxol significantly increased tear osmolarity in the eyes of healthy subjects, according to a study. The ...

A landmark Phase 3 clinical trial is beginning in the UK, testing whether a common cough medicine can be used to treat Parkinson's disease. Early studies indicate the 50-year-old drug can cross into ...

Ambroxol, long used for coughs in Europe, stabilized symptoms and brain-damage markers in Parkinson’s dementia patients over 12 months, whereas placebo patients worsened. Those with high-risk genes ...

Dementia poses a major health challenge with no safe, affordable treatments to slow its progression. Researchers at Lawson Research Institute (Lawson), the research arm of St. Joseph's Health Care ...

Activist investor Jana Partners has built a stake in medical device maker Cooper Companies and plans to push for strategic alternatives, two sources familiar with the matter said on Sunday.

A commonly sold cough syrup in Europe could potentially slow down progression of dementia in patients with Parkinson’s disease, a new study suggests. Nearly half of those diagnosed with Parkinson’s ...